Home / Rifampicin / Norway
NO ATC J04AB02 · updated 2 Nov 2026
Rifampicin shortage in Norway
Is there a Rifampicin shortage in Norway?
Yes. As of 2 Nov 2026, 3 Rifampicin products are reported short in Norway, the first since 16 Mar 2026. The company estimate for the return is 20 Dec 2026 (latest 3 May 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Ireland, Austria, Sweden, Australia. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Rimactan 300 mg kapsel, hard, 100 stk blisterpakning | Sandoz Gmbh | 16 Mar 2026 | 20 Dec 2026 | Manufacturing problem Produksjonsproblemer |
| NO | Rimactan 150 mg kapsel, hard, 100 stk blisterpakning | Sandoz Gmbh | 20 Aug 2026 | 20 Dec 2026 | Manufacturing problem Produksjonsproblemer |
| NO | Rimactan 300 mg kapsel, hard, 100 stk blisterpakning | 2care4 ApS | 20 Oct 2026 | 3 May 2027 | Distribution or logistics Distribusjonsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).